8-K
Current Report
Compass Therapeutics, Inc. Filed Acc 0001171843-22-004019
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading f8k_053122.htm…